CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-10-05 | Cox Gerald Frank Chief Medical Officer | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2016-09-09 | Albright Charles Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2016-09-08 | Bitterman Kevin Director | Sale | −500,000 | $16.80 | $8.4M | 4,156,173 |
| 2016-09-08 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Sale | −500,000 | $16.80 | $8.4M | 4,156,173 |
| 2016-09-06 | STARR KEVIN P 10% owner | Sale | −5,890 | $15.90 | $94K | 0 |
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Option exercise | +1,000 | $0.65 | $650 | 118,788 |
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Sale | −1,000 | $20.00 | $20K | 117,788 |
| 2016-08-23 | Glucksmann Alexandra Chief Operating Officer | Option exercise · Stock Option (right to buy) | −1,000 | 37,461 | ||
| 2016-08-16 | Third Rock Ventures III, L.P. 10% owner | Other disposition | −750,000 | 3,906,176 | ||
| 2016-08-11 | Cole Douglas G. Director | Other acquisition | +1,485 | 1,485 | ||
| 2016-08-11 | Flagship Ventures Fund IV, L.P. 10% owner | Other disposition | −1,200,000 | 2,764,256 | ||
| 2016-08-11 | Flagship Ventures Fund IV, L.P. 10% owner | Other disposition | −300,000 | 691,060 | ||
| 2016-08-11 | Flagship Ventures Fund IV, L.P. 10% owner | Other disposition | −50,271 | 0 | ||
| 2016-07-28 | Vaishnaw Akshay Director | Grant or award · Stock Option (right to buy) | +23,076 | 23,076 | ||
| 2016-02-08 | bng0, LLC 10% owner | Conversion | +2,649,572 | 2,649,572 | ||
| 2016-02-08 | bng0, LLC 10% owner | Conversion · Series B Preferred Stock | −6,888,888 | 0 | ||
| 2016-02-08 | Flagship Ventures Fund IV, L.P. 10% owner | Conversion | +2,039,549 | 2,039,549 | ||
| 2016-02-08 | Flagship Ventures Fund IV, L.P. 10% owner | Conversion | +1,617,015 | 3,656,564 | ||
| 2016-02-08 | Flagship Ventures Fund IV, L.P. 10% owner | Conversion | +307,692 | 3,964,256 | ||
| 2016-02-08 | Flagship Ventures Fund IV, L.P. 10% owner | Conversion | +509,885 | 509,885 |
Page 26 of 30 · 588 trades